Last reviewed · How we verify

NCT04278456

Postpartum Depression

Status unknown Last updated 20 February 2020
What this trial tests

trial testing postpartum depression in Postpartum Depression in 300 participants. Status unknown.

Timeline
21 March 2020
Primary endpoint
21 May 2020
21 July 2020

Quick facts

Lead sponsorErzincan University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date21 March 2020
Primary completion21 May 2020
Estimated completion21 July 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Erzincan University

Who can join

Adults 18 to 45, female only, with Postpartum Depression or Melatonin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our aim was to diagnose and initiate early treatment for postpartum depression by detecting the changes of melatonin levels in c-sections with different antesthesia modalities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postpartum Depression

Currently open trials in the same condition.

Other Erzincan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04278456.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing